share_log

iBio Inc | CORRESP: CORRESP

iBio Inc | CORRESP: CORRESP

iBio Inc | CORRESP:信函
美股SEC公告 ·  08/02 13:05

Moomoo AI 已提取核心信息

iBio Inc has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, initially filed on July 3, 2024. The company seeks to have the registration become effective on August 6, 2024, at 4:00 p.m. Eastern Time. This request was communicated through a letter addressed to Daniel Crawford at the SEC, with the understanding that the company acknowledges its responsibilities under federal securities laws. iBio Inc has authorized Leslie Marlow of Blank Rome LLP to modify or withdraw the acceleration request if necessary. The SEC staff has been asked to contact Leslie Marlow or Melissa Palat Murawsky for any inquiries and to notify them once the acceleration has been granted.
iBio Inc has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, initially filed on July 3, 2024. The company seeks to have the registration become effective on August 6, 2024, at 4:00 p.m. Eastern Time. This request was communicated through a letter addressed to Daniel Crawford at the SEC, with the understanding that the company acknowledges its responsibilities under federal securities laws. iBio Inc has authorized Leslie Marlow of Blank Rome LLP to modify or withdraw the acceleration request if necessary. The SEC staff has been asked to contact Leslie Marlow or Melissa Palat Murawsky for any inquiries and to notify them once the acceleration has been granted.
ibio inc已正式要求美国证券交易所(SEC)加速其在2024年7月3日首次递交的S-3表格注册声明的生效日期。公司希望该注册生效时间为2024年8月6日下午4点(美国东部时间)。这一请求通过信函发送给了SEC的丹尼尔·克劳福德(Daniel Crawford),公司知道并承认其在联邦证券法下的责任。ibio inc已授权Blank Rome LLP的Leslie Marlow在必要时修改或撤回加速请求。已要求SEC的工作人员联系Leslie Marlow或Melissa Palat Murawsky以解答任何疑问,并在加速获得批准后通知他们。
ibio inc已正式要求美国证券交易所(SEC)加速其在2024年7月3日首次递交的S-3表格注册声明的生效日期。公司希望该注册生效时间为2024年8月6日下午4点(美国东部时间)。这一请求通过信函发送给了SEC的丹尼尔·克劳福德(Daniel Crawford),公司知道并承认其在联邦证券法下的责任。ibio inc已授权Blank Rome LLP的Leslie Marlow在必要时修改或撤回加速请求。已要求SEC的工作人员联系Leslie Marlow或Melissa Palat Murawsky以解答任何疑问,并在加速获得批准后通知他们。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息